JAK2 and neoplasm: Authors reported that JAK2-specific inhibitors had been shown in reducing tumor growth in TNBC cells, but JAK1/STAT3 inhibitor had little effect, sometimes counteracting the JAK2 specific inhibition on TNBC in an in vivo model [195].